Matthias Hepprich

11PUBLICATIONS
13CO-AUTHORS
Behavioural epidemiologyInnate immunityMajor global burdens of diseasePharmacogenomicsPublic health nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 02, 2026
The power of lifestyle intervention to induce glycaemic control in a patient with newly diagnosed type 2 diabetes and HbA1c >10.

Antonio Ferreira, Thomas Züger, Marc Y Donath

|Mar 04, 2026
Acute interleukin-1β antagonism decreases systemic inflammation, increases GLP-1 release, and modulates insulin secretion in individuals with prediabetes.

Justus S Fischer, Matthias Hepprich, Marco Cattaneo

|Aug 01, 2025
Exenatide for diagnosing endogenous hyperinsulinemic hypoglycemia: a randomized placebo-controlled, double-blind, cross-over proof-of-principle study.

Matthias Hepprich, Christina Romberg, Jonathan Mudry

|May 27, 2025
Canakinumab for the treatment of postprandial hypoglycaemia: study protocol for a randomised, placebo-controlled, parallel-group, double-blind, multicentric, superiority trial-the CanpHy study.

Matthias Hepprich, Justus Fischer, Marco Cattaneo

|Nov 10, 2023
Awareness and knowledge of diabetic ketoacidosis in people with type 1 diabetes: a cross-sectional, multicenter survey.

Matthias Hepprich, Pia Roser, Sebastian Stiebitz

|Apr 05, 2023
Glucocorticoid withdrawal and glucocorticoid-induced adrenal insufficiency: Study protocol of the randomized controlled «TOASST" (Taper Or Abrupt Steroid STop) multicenter trial.

Mathis Komminoth, Marc Y Donath, Matthias Hepprich

Pageof 2

Frequent Collaborators

3 joint publications

Marco Cattaneo

2 joint publications

Emanuel R Christ

1 joint publications

Mathis Komminoth

1 joint publications

Claudine A Blum